Cellectis S.A. (NASDAQ:CLLS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Cellectis S.A. (NASDAQ:CLLS - Get Free Report) have been given an average rating of "Moderate Buy" by the five ratings firms that are presently covering the stock, Marketbeat Ratings...